|
[1]
|
Raherison, C. and Girodet, P. (2009) Epidemiology of COPD. European Respiratory Review, 18, 213-221. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Singh, D., Agusti, A., Anzueto, A., et al. (2019) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019. European Respiratory Journal, 53, Article ID: 1900164. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chai, Q., Lu, Z., Liu, Z., et al. (2020) Lung Gene Expression Signatures Suggest Pathogenic Links and Molecular Markers for Pulmonary Tuberculosis, Adenocarcinoma and Sar-coidosis. Communications Biology, 3, Article No. 604. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Harding, E. (2020) WHO Global Progress Report on Tuberculo-sis Elimination. The Lancet Respiratory Medicine, 8, Article No. 19. [Google Scholar] [CrossRef]
|
|
[5]
|
Lee, C.-H., Lee, M.-C., Lin, H.-H., et al. (2012) Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease. PLOS ONE, 7, e37978. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Polverino, F. and Kheradmand, F. (2021) COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Frontiers in Medicine, 7, Article ID: 627278. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chakrabarti, B., Calverley, P.M. and Davies, P.D. (2007) Tuber-culosis and Its Incidence, Special Nature, and Relationship with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 2, 263-272.
|
|
[8]
|
Shimeles, E., Enquselassie, F., Aseffa, A., et al. (2019) Risk Factors for Tuberculosis: A Case-Control Study in Addis Ababa, Ethiopia. PLOS ONE, 14, e0214235. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Papi, A., Bellettato, C.M., Braccioni, F., et al. (2006) Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations. American Journal of Res-piratory and Critical Care Medicine, 173, 1114-1121. [Google Scholar] [CrossRef]
|
|
[10]
|
Mallia, P., Contoli, M., Caramori, G., et al. (2007) Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Focus on Virus Induced Exacerbations. Current Pharmaceutical Design, 13, 73-97. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Han, M.K., Quibrera, P.M., Carretta, E.E., et al. (2017) Fre-quency of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: An Analysis of the SPIROMICS Cohort. The Lancet Respiratory Medicine, 5, 619-626. [Google Scholar] [CrossRef]
|
|
[12]
|
Attaway, A.A., Zein, J. and Hatipoğlu, U.S. (2020) SARS-CoV-2 Infection in the COPD Population Is Associated with Increased Healthcare Utilization: An Analysis of Cleveland Clinic’s COVID-19 Registry. EClinicalMedicine, 26, Article ID: 100515. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Agusti, A., Fabbri, L.M., Singh, D., et al. (2018) Inhaled Corti-costeroids in COPD: Friend or Foe? European Respiratory Journal, 52, Article ID: 1801219. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Brassard, P., Suissa, S., Kezouh, A., et al. (2011) Inhaled Cor-ticosteroids and Risk of Tuberculosis in Patients with Respiratory Diseases. American Journal of Respiratory and Criti-cal Care Medicine, 183, 675-678. [Google Scholar] [CrossRef]
|
|
[15]
|
Fan, H., Wu, F., Liu, J., et al. (2021) Pulmonary Tuberculosis as a Risk Factor for Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Annals of Translational Medicine, 9, Article No. 390. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Hooper, R., Burney, P., Vollmer, W.M., et al. (2012) Risk Factors for COPD Spirometrically Defined from the Lower Limit of Normal in the BOLD Project. European Respiratory Journal, 39, 1343-1353. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wada, H., Ikeda, A., Maruyama, K., et al. (2021) Low BMI and Weight Loss Aggravate COPD Mortality in Men, Findings from a Large Prospective Cohort: The JACC Study. Scientific Reports, 11, Article No. 1531. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Gläser, S., Krüger, S., Merkel, M., et al. (2015) Chronic Ob-structive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature. Respiration, 89, 253-264. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ma, L., Chen, X. and Gao, M. (2022) Analysis on the Risk Factors of Malnutrition in Type 2 Diabetes Mellitus Patients with Pulmonary Tuberculosis. Infection and Drug Resistance, 15, 7555-7564. [Google Scholar] [CrossRef]
|
|
[20]
|
Wang, X., Luo, L., Zhang, D., et al. (2022) Factors Associated with Nutritional Risk in Patients with Pulmonary Tuberculosis and Structural Lung Disease: A Hospital-Based Cross-Sectional Study. Journal of Multidisciplinary Healthcare, 15, 1799-1807. [Google Scholar] [CrossRef]
|
|
[21]
|
Chu, A.L., Lecca, L.W., Calderón, R.I., et al. (2021) Smoking Cessa-tion in Tuberculosis Patients and the Risk of Tuberculosis Infection in Child Household Contacts. Clinical Infectious Diseases, 73, 1500-1506. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Park, H.Y., Kang, D., Shin, S.H., et al. (2022) Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society, 19, 640-648. [Google Scholar] [CrossRef]
|
|
[23]
|
Nnoaham, K.E. and Clarke, A. (2008) Low Serum Vit-amin D Levels and Tuberculosis: A Systematic Review and Meta-Analysis. International Journal of Epidemiology, 37, 113-119. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Svanes, C., Sunyer, J., Plana, E., et al. (2010) Early Life Origins of Chronic Obstructive Pulmonary Disease. Thorax, 65, 14-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Sarkar, M., Madabhavi, I. and Kumar, K. (2017) Tuberculosis Asso-ciated Chronic Obstructive Pulmonary Disease. The Clinical Respiratory Journal, 11, 285-295. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kanervisto, M., Vasankari, T., Laitinen, T., et al. (2011) Low Socioeconomic Status Is Associated with Chronic Obstructive Airway Diseases. Respiratory Medicine, 105, 1140-1146. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Sakornsakolpat, P., Prokopenko, D., Lamontagne, M., et al. (2019) Genetic Landscape of Chronic Obstructive Pulmonary Disease Identifies Heterogeneous Cell-Type and Phenotype Asso-ciations. Nature Genetics, 51, 494-505. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Ma, L. and Gao, M. (2022) Analysis of Clinical Characteristics and Risk Factors for Drug Resistance in Newly-Treated Patients with Pulmonary Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease. Infection and Drug Resistance, 15, 4861-4869. [Google Scholar] [CrossRef]
|
|
[29]
|
Menezes, A.M.B., Hallal, P.C., Perez-Padilla, R., et al. (2007) Tuber-culosis and Airflow Obstruction: Evidence from the PLATINO Study in Latin America. European Respiratory Journal, 30, 1180-1185. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Matheson, M.C., Bowatte, G., Perret, J.L., et al. (2018) Predic-tion Models for the Development of COPD: A Systematic Review. International Journal of Chronic Obstructive Pul-monary Disease, 13, 1927-1935. [Google Scholar] [CrossRef]
|
|
[31]
|
Lee, J. and Chang, J. (2003) Lung Function in Patients with Chronic Airflow Obstruction Due to Tuberculous Destroyed Lung. Respiratory Medicine, 97, 1237-1242. [Google Scholar] [CrossRef]
|
|
[32]
|
Wang, Y., Li, Z. and Li, F. (2023) Impact of Previous Pul-monary Tuberculosis on Chronic Obstructive Pulmonary Disease: Baseline Results from a Prospective Cohort Study. Combinatorial Chemistry & High Throughput Screening, 26, 93-102. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Kadowaki, T., Yano, S., Wakabayashi, K., et al. (2011) Pulmonary Tuberculosis with Atypical Radiological Findings in a Patient with Chronic Obstructive Pulmonary Disease. Kekkaku [Tuberculosis], 86, 763-766.
|
|
[34]
|
Jung, J.-W., Choi, J.-C., Shin, J.-W., et al. (2015) Pulmonary Impairment in Tuberculosis Survivors: The Korean National Health and Nutrition Examination Survey 2008-2012. PLOS ONE, 10, e0141230. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Jin, J., Li, S., Yu, W., et al. (2018) Emphysema and Bronchiec-tasis in COPD Patients with Previous Pulmonary Tuberculosis: Computed Tomography Features and Clinical Implica-tions. International Journal of Chronic Obstructive Pulmonary Disease, 13, 375-384. [Google Scholar] [CrossRef]
|
|
[36]
|
Pefura-Yone, E.W., Kengne, A.P., Tagne-Kamdem, P.E., et al. (2014) Clinical Significance of Low Forced Expiratory Flow between 25% and 75% of Vital Capacity Following Treated Pul-monary Tuberculosis: A Cross-Sectional Study. BMJ Open, 4, e005361. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Nishi, M.P., Mancuzo, E.V., Sulmonett, N., et al. (2021) Pul-monary Functional Assessment: Longitudinal Study after Treatment of Pulmonary Tuberculosis. Revista do Instituto de Medicina Tropical de São Paulo, 63, e65. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Tiberi, S., Zumla, A. and Migliori, G.B. (2019) Multidrug and Extensively Drug-Resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment. Infectious Dis-ease Clinics, 33, 1063-1085. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Shadrach, B.J., Kumar, S., Deokar, K., et al. (2021) A Study of Multidrug Resistant Tuberculosis among Symptomatic Household Contacts of MDR-TB Patients. Indian Journal of Tu-berculosis, 68, 25-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Chung, K.-P., Chen, J.-Y., Lee, C.-H., et al. (2011) Trends and Pre-dictors of Changes in Pulmonary Function after Treatment for Pulmonary Tuberculosis. Clinics, 66, 549-556. [Google Scholar] [CrossRef]
|